Hetero Recalls Simvastatin 40mg Due to Razor Blade Hazard
Hetero Labs recalls Simvastatin Tablets USP 40 mg (1000-count) due to a metallic razor blade found in one bottle. Check your lot number.
Stop using this now
Presence of foreign substance: metallic razor blade was found in one bottle.
Contact the company
What happened, in plain English
Hetero Labs, Ltd. - Unit III is recalling Simvastatin Tablets, USP, 40 mg, specifically the 1000-count bottles manufactured for Camber Pharmaceuticals, Inc. The recall was initiated because a metallic razor blade was discovered inside one of the bottles. This poses a serious physical injury risk if ingested. Read more at govinfonow.com/recall/41002-hetero-recalls-simvastatin-40mg-due-to-razor-blade-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/41002-hetero-recalls-simvastatin-40mg-due-to-razor-blade-hazard · Updated October 11, 2026 · FDA enforcement record: FDA #D-0223-2018
Cite this page
“Hetero Recalls Simvastatin 40mg Due to Razor Blade Hazard.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41002-hetero-recalls-simvastatin-40mg-due-to-razor-blade-hazard. Based on FDA recall #D-0223-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0223-2018%22&limit=1).
Why it’s dangerous
The presence of a metallic razor blade within the medication bottle creates a severe risk of internal injury or choking if the contaminated tablets are consumed.
Who’s affected
Individuals who have purchased Simvastatin Tablets USP 40 mg in 1000-count bottles from Camber Pharmaceuticals, Inc., distributed nationwide in the U.S. before December 22, 2017.
How to tell if you have this one
Check your bottle for the following details: Product is Simvastatin Tablets, USP, 40 mg, in a 1000-count bottle. Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ. NDC 31722-513-10. Lot Number E171280 with an expiration date of 06/19.
- Brand
Hetero Labs- Category
Drug
What to do — step by step
Stop using the medication
Do not consume any tablets from the affected bottle due to the risk of injury from the foreign object.
Contact your pharmacy or doctor
Reach out to your healthcare provider or pharmacist immediately for guidance on replacing the medication and next steps.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0223-2018 (December 22, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0223-2018 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.